Compare WDS & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDS | ALC |
|---|---|---|
| Founded | 1954 | 1945 |
| Country | Australia | Switzerland |
| Employees | 4667 | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8B | 35.9B |
| IPO Year | N/A | 2002 |
| Metric | WDS | ALC |
|---|---|---|
| Price | $22.94 | $63.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $89.38 |
| AVG Volume (30 Days) | 770.0K | ★ 2.0M |
| Earning Date | 02-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.50% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.14 | $7.99 |
| Revenue Next Year | $4.92 | $6.38 |
| P/E Ratio | ★ $11.81 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.58 | $61.84 |
| 52 Week High | $25.19 | $92.55 |
| Indicator | WDS | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 29.61 |
| Support Level | $22.17 | N/A |
| Resistance Level | $24.98 | $81.92 |
| Average True Range (ATR) | 0.39 | 1.62 |
| MACD | -0.06 | -0.80 |
| Stochastic Oscillator | 59.09 | 13.75 |
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.